^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Ampulla of Vater Carcinoma

4d
Recurrence patterns and predictors after pancreaticoduodenectomy for ampullary carcinoma. (PubMed, HPB (Oxford))
Recurrence is predominantly systemic and driven by nodal status and CA19‑9, adjuvant chemotherapy mitigates distant failure-particularly in N1-and the identification of delayed gastric emptying as an independent predictor underscores the oncologic importance of perioperative optimization; histologic subtype was not independently prognostic.
Journal
|
CA 19-9 (Cancer antigen 19-9)
14d
Clinical characteristics of ampullary tumors and analysis of the efficacy and safety of endoscopic papillectomy (ChiCTR2500112237)
P=N/A, N=182, Not yet recruiting, Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital; Department of Gastroenterology, The First Medical Center of
New trial
14d
The Impact of Braun Anastomosis with Different Lengths of Output Loop on the Major Clinical Outcomes After Pancreatectomy: A Prospective, Randomized, Controlled, Multicenter Clinical Study (ChiCTR2600116777)
P=N/A, N=60, Recruiting, The First Affiliated Hospital of Guangxi Medical University; The First Affiliated Hospital of Guangxi Medical University
New trial
15d
Association Between Tumor-Infiltrating Immune Cells and Early Recurrence in Ampulla of Vater Carcinoma. (PubMed, Cureus)
However, the present results should be interpreted as exploratory and hypothesis-generating. Further large-scale studies are warranted to clarify the biological significance of these immune features and their potential therapeutic implications.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • CD8 (cluster of differentiation 8) • PD-1 (Programmed cell death 1) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • CD4 (CD4 Molecule) • FOXP3 (Forkhead Box P3) • CA 19-9 (Cancer antigen 19-9)
19d
Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort study. (PubMed, EClinicalMedicine)
These findings suggest that current surveillance recommendations for individuals with LS should be re-evaluated. Lynch-Polyposis.
Journal
|
MLH1 (MutL homolog 1) • MSH6 (MutS homolog 6) • MSH2 (MutS Homolog 2) • PMS2 (PMS1 protein homolog 2) • EPCAM (Epithelial cell adhesion molecule)
23d
Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy (clinicaltrials.gov)
P=N/A, N=90, Recruiting, Minia University | Not yet recruiting --> Recruiting
Enrollment open
24d
The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone (clinicaltrials.gov)
P=N/A, N=320, Completed, State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital | Active, not recruiting --> Completed
Trial completion
1m
New trial
2ms
Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis. (PubMed, JHEP Rep)
However, it also reinforces the need for careful patient selection to avoid unnecessary surgical morbidity when the anticipated oncological benefit is limited. Overall, these findings emphasize the need for prospective, age-stratified studies to better define prognostic models and guide personalized therapeutic approaches for this distinct patient population.
Retrospective data • Journal
|
FGFR2 (Fibroblast growth factor receptor 2)
|
FGFR2 fusion
2ms
PORTAL: Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors (clinicaltrials.gov)
P=N/A, N=268, Completed, Ruijin Hospital | Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Nov 2022 --> Feb 2025
Trial completion • Phase classification • Trial completion date • Head-to-Head
2ms
New trial
|
5-fluorouracil • oxaliplatin • leucovorin calcium